X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
melanoma (11) 11
humans (10) 10
male (7) 7
oncology (7) 7
female (5) 5
index medicus (5) 5
middle aged (5) 5
aged (4) 4
survival (4) 4
aged, 80 and over (3) 3
braf (3) 3
complications and side effects (3) 3
dermatology (3) 3
melanoma - drug therapy (3) 3
melanoma - genetics (3) 3
metastasis (3) 3
metastatic melanoma (3) 3
prognosis (3) 3
surgery (3) 3
vemurafenib (3) 3
adolescent (2) 2
adult (2) 2
analysis (2) 2
animals (2) 2
anti-ctla-4 (2) 2
colitis (2) 2
cutaneous melanoma (2) 2
drug therapy (2) 2
gene mutations (2) 2
gtp phosphohydrolases - genetics (2) 2
health aspects (2) 2
immunology (2) 2
immunotherapy (2) 2
improved survival (2) 2
indoles - adverse effects (2) 2
lymphatic metastasis (2) 2
malignant-melanoma (2) 2
medicine, research & experimental (2) 2
mek inhibition (2) 2
melanocytes - metabolism (2) 2
melanoma - diagnostic imaging (2) 2
membrane proteins - genetics (2) 2
mice (2) 2
ophthalmology (2) 2
primary cutaneous melanoma (2) 2
prospective studies (2) 2
protein kinase inhibitors - adverse effects (2) 2
risk factors (2) 2
sensitivity and specificity (2) 2
skin neoplasms - diagnostic imaging (2) 2
skin neoplasms - genetics (2) 2
sulfonamides - adverse effects (2) 2
abridged index medicus (1) 1
abscopal effect (1) 1
acoustics (1) 1
activation (1) 1
acute respiratory distress syndrome (1) 1
adjuvant therapy (1) 1
adverse events (1) 1
allelic imbalance (1) 1
american joint committee (1) 1
anti-pd-1 monoclonal antibody (1) 1
anti-tnf alpha (1) 1
aqp2 (1) 1
aquaporin 2 (1) 1
aquaporins (1) 1
article (1) 1
bacterial pneumonia (1) 1
beta catenin - metabolism (1) 1
beta catenin - physiology (1) 1
biomarker (1) 1
biomarkers, tumor - genetics (1) 1
biopsy (1) 1
blotting, western (1) 1
braf inhibitors (1) 1
brain metastases (1) 1
bronchoalveolar lavage fluid - cytology (1) 1
cadherins - metabolism (1) 1
cancer (1) 1
cancer cells (1) 1
cancer research (1) 1
cancer staging system (1) 1
care and treatment (1) 1
case report (1) 1
case studies (1) 1
caveolin 1 - genetics (1) 1
cell biology (1) 1
cell division (1) 1
cell line, tumor (1) 1
cell membranes (1) 1
cell-migration (1) 1
checkpoint inhibitors (1) 1
chemotherapy (1) 1
child (1) 1
chromosome duplication (1) 1
chromosomes, human, pair 1 (1) 1
clinical-outcomes (1) 1
combined nivolumab (1) 1
ct imaging (1) 1
dabrafenib plus trametinib (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21549 - e21549
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 9537 - 9537
Journal Article
Nature Communications, ISSN 2041-1723, 08/2015, Volume 6, Issue 1, p. 8093
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e21008 - e21008
Journal Article
Experimental Dermatology, ISSN 0906-6705, 06/2016, Volume 25, Issue 6, pp. 472 - 474
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 9016 - 9016
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e20066 - e20066
Journal Article
JOURNAL OF IMMUNOTHERAPY, ISSN 1524-9557, 06/2019, Volume 42, Issue 5, pp. 175 - 179
Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and... 
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | colitis | MONOTHERAPY | COMBINED NIVOLUMAB | melanoma | anti-TNF alpha | IMMUNOLOGY | CANCER | CHEMOTHERAPY | PEMBROLIZUMAB | TOXICITIES | ANTI-CTLA-4 | ONCOLOGY | ADVERSE EVENTS | IPILIMUMAB
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 12/2014, Volume 132, Issue 12, p. 1421
  This case series highlights the risk of uveitis in patients treated with vemurafenib for unresectable or metastatic cutaneous melanoma. To assess the... 
Side effects | Inhibitor drugs | Melanoma | Eye diseases | Ophthalmology | Drug therapy
Journal Article
OncoImmunology, ISSN 2162-4011, 07/2018, Volume 7, Issue 7, p. e1442166
Information on the role of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma patients is limited. We report on a prospective cohort of advanced... 
radiotherapy | melanoma | anti-PD-1 monoclonal antibody | abscopal effect | immunotherapy | SURVIVAL | STEREOTACTIC RADIATION | IMMUNOLOGY | METASTATIC MELANOMA | CHECKPOINT INHIBITORS | THERAPY | ANTI-CTLA-4 | ONCOLOGY | BRAIN METASTASES | NIVOLUMAB | CLINICAL-OUTCOMES
Journal Article
Experimental Dermatology, ISSN 0906-6705, 06/2016, Volume 25, Issue 6, pp. 472 - 474
One‐fifth of cutaneous melanomas have dominant gain‐of‐function mutations of the NRAS oncogene. We report the first two cases of increasing NRAS mutant allele... 
NRAS melanoma | homozygous mutation | biomarker | polysomy | allelic imbalance | Polysomy | Biomarker | Allelic imbalance | Homozygous mutation | BRAF | MUTATIONS | DERMATOLOGY | Chromosomes, Human, Pair 1 | Chromosome Duplication | GTP Phosphohydrolases - genetics | Melanoma - genetics | Membrane Proteins - genetics | Humans | Middle Aged | Male | Aged | Gain of Function Mutation | Metastasis | Gene mutations | Analysis | Melanoma
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2012, Volume 19, Issue 13, pp. 4314 - 4321
BRAF V600 mutations are frequent in melanomas, and BRAFV600-targeted therapy have dramatic, but often transitory, efficacy in stage IV patients. Prognosis of... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2012, Volume 19, Issue 13, p. 4314
BRAF .sup.V600 mutations are frequent in melanomas, and BRAF.sup.V600-targeted therapy have dramatic, but often transitory, efficacy in stage IV patients.... 
Prognosis | Gene mutations | Analysis | Surgery | DNA | Melanoma | Genetic aspects | Metastasis | Public health
Journal Article
Journal of immunotherapy (Hagerstown, Md. : 1997), 05/2019
Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.